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Citrus Polyphenols in Brain Health
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David Vauzour*
Norwich Medical School, Biomedical Research Centre, Faculty of Medicine and Health Sciences, University of East Anglia,
Norwich, United Kingdom
In addition to essential micronutrients such as vitamin C, citrus fruits represent a
considerably rich source of non-essential bioactive compounds, in particular flavanones
which form a sub-set of the flavonoid group. Preclinical studies have demonstrated
the neuroprotective potential of citrus flavonoids and have highlighted both the well-
established (anti-inflammatory and anti-oxidative properties), and newly emerging
(influence upon blood-brain barrier function/integrity) mechanistic actions by which
these neurological effects are mediated. Encouragingly, results from human studies,
although limited in number, appear to support this preclinical basis, with improvements
in cognitive performance and disease risk observed across healthy and disease states.
Therefore, citrus fruits – both as whole fruit and 100% juices – should be encouraged
within the diet for their potential neurological benefit. In addition, there should be further
exploration of citrus polyphenols to establish therapeutic efficacy, particularly in the
context of well-designed human interventions.
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INTRODUCTION
A varied and balanced diet, rich in plant-derived material (fruit and vegetables), is widely regarded
as optimal for maintaining overall health and wellbeing. Unfortunately, typical modern dietary
preferences are increasingly skewed in favor of nutrient poor, calorie dense, ultra-processed food
choices. Combined with the background of an aging population, circumstances have produced
a ‘perfect storm’ leading to a surge in metabolic disease burden, including rising incidence of
neurodegenerative conditions which present significant societal and economic challenges.
Plant bioactives such as polyphenolic compounds have shown potential in negating the
metabolic disease process (Chiva-Blanch and Badimon, 2017). Polyphenol describes a broad range
of non-essential, usually naturally occurring compounds of which fruits and vegetables represent
a significant source. The use of polyphenolic compounds in a therapeutic capacity is being
increasingly considered, as we ‘return to nature’ to find sources of potential drug candidates (Xiao,
2017; Bellavite and Donzelli, 2020). Although currently lacking confirmation through rigorous
long-term randomized control trial (RCT) evidence, the use of polyphenolic compounds in the
prevention of cardiovascular disease appears promising (Parmenter et al., 2020). Indeed, an inverse
relationship between polyphenolic compound consumption and cardiovascular disease mortality,
risk and biomarkers are consistently highlighted in observational and preclinical studies. Given
that cardiovascular health is a contributing factor to brain health, and cardiovascular disease is a
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significant risk factor for various forms of dementia, the benefits
of polyphenols may also extend to brain functions.
Intriguingly, the mechanistic basis by which polyphenols may
contribute to brain health and cognition extends further than
those associated with cardiovascular health to include anti-
inflammatory and anti-oxidative capabilities (Vauzour et al.,
2017; Flanagan et al., 2020). In addition, the developing role of
the gut microbiota and its interplay with plant bioactives offers a
novel route by which physiological effects can be exerted (Kumar
Singh et al., 2019; Catalkaya et al., 2020). Continuing to reveal
the underlying biochemical processes to which these compounds
exert their effects is essential to utilizing their potential in
brain health and disease, however, the importance of evaluating
these compounds clinically cannot be underestimated. In this
review, we will examine the current evidence on polyphenols
and their effects on brain health, focusing specifically on citrus
polyphenols since these are one of the main groups of flavonoids
in the European diet.
PLANT POLYPHENOLS
Synthesized by plants to form either structural/functional tissue,
or as a defense mechanism against pathogens and herbivores,
polyphenol describes a compound with a chemical structure
containing one or more phenolic rings (Frank et al., 2020).
Further classifications can be made based upon phenolic ring
numbers, and associated structures binding these rings together
(e.g., oxygenated heterocycle) (Cutrim and Cortez, 2018). With
an estimated 15,000 varieties currently identified, flavonoids
represent a considerably diverse class of polyphenol (Xiao,
2017). The structural basis of the flavonoid is a 15-carbon atom
structure, forming a C6–C3–C6 heterocyclic skeleton, consisting
of two benzene rings, linked to a heterocyclic ring (flavon
ring). Ubiquitous in plant-based diets, flavonoids are the main
polyphenolic component of citrus fruits. Differing heterocyclic
ring oxidization gives rise to further subclasses: flavanones,
flavonols, flavones, and anthocyanins (present in blood oranges).
Citrus fruits (Rutaceae) such as oranges, grapefruit, lemons
and limes are a particularly rich source of flavanones and
are therefore sometimes called citroflavonoids. Flavanones are
also present in other food sources such as seasoning herbs
(e.g., rosemary, oregano, peppermint), but in much lower
concentrations (Rothwell et al., 2013).
Hesperidin (hesperetin-7-O-rutinoside) is a major citrus
flavanone found in all citrus fruits (Jadeja and Devkar,
2014), reaching concentrations of 25.8–38.3 g/kg in sweet
oranges (Iglesias-Carres et al., 2019) and up to 520 mg/L
in orange juice (De Rycker et al., 2020). Hesperidin is also
the most common of the flavonoid monomers in European
diets with an intake of approximately 27 mg/daily (Zamora-
Ros et al., 2015), although regional variations are observed
(Wang et al., 2015a). Oranges and orange juices also contain
naringenin-7-O-rutinoside (narirutin) in addition to smaller
quantities of hesperetin-7-O-rutinoside-3′-O-glucoside, 4′-O-
methyl-naringenin-7-O-rutinoside (didymin), and eriodictyol-7-
O-rutinoside (eriocitrin) (Kay et al., 2017). Such compounds
are believed to be responsible for many citrus related biological
actions, although several other bioactives are also present
in various citrus fruit and juice sources (e.g., anthocyanins,
flavonols, carotenoids, pectins), and are therefore likely to also
possess bioactive properties (Figure 1).
MARKERS OF BRAIN HEALTH AND
FUNCTION
Markers of brain health and disease are key to understanding and
treating neurological conditions. Development of sophisticated
neuroimaging techniques [e.g., Positron Emission topography
(PET) and functional Magnetic Resonance Imaging (fMRI)] has
enabled subtle differences in brain activity, metabolism and
structure to be monitored and distinguished between healthy
and disease states (Agosta et al., 2013). Future incorporation
of artificial intelligence techniques, e.g., deep learning, will
likely enhance the prospect and feasibility of early detection
of neurological conditions (Noor et al., 2020). However, the
cost, expertise, and scalability of neuroimaging limits widespread
use. Therefore, biological markers, detectable in the periphery
(commonly cerebral spinal fluid or blood) remain equally
important, and better suited for screening purposes. Below we
discuss some specific markers of brain health in more detail.
Neurotrophins
Neurotrophins are blood-brain barrier permeable signaling
molecules with a crucial role in synaptic plasticity, neuronal
cell survival and neurogenesis/synaptogenesis (Gibon and
Barker, 2017). The presence of neurotrophins in the peripheral
circulation makes them an ideal candidate for monitoring
brain health and function. Of the neurotrophins, brain-derived
neurotrophic factor (BDNF) has been the most extensively
studied in the context of brain health, with peripheral levels
associating with cognitive performance and neurological diseases
(Nascimento et al., 2014; Küster et al., 2017; Palasz et al.,
2020). BDNF levels have been reported to increase linearly
to the age of 65, after which their levels markedly decrease
(Neshatdoust et al., 2016). Interestingly, this predominantly
corresponds to various MRI measures of brain health and
cognition, although a high level of inter-study heterogeneity
exists (McPhee et al., 2020).
Blood-Brain Barrier
Loss of blood-brain barrier (BBB) integrity/function is
considered an early process of neurodegenerative disease.
Thus, markers of BBB permeability and/or breakdown are
being actively explored as measures of brain health and disease
risk. Leakiness of BBB can be determined using MRI (dynamic
contrast-enhanced MRI) or PET with various tracers such as
gadolinium or 18F-fluoro-2-deoxyglucose (FDG) respectively
(Sweeney et al., 2018). Additionally, MRI (T2∗-weighted and
susceptibility-weighted imaging MRI) can detect a chronic
accumulation of small blood products, ‘microbleeds,’ thought
to be linked to BBB breakdown. Peripheral markers of BBB
function have also been established. CSF soluble platelet-derived
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FIGURE 1 | Polyphenol categorization – polyphenol describes a compound with a chemical structure containing one or more phenolic rings and can be classified
into four main groups: phenolic acids, lignans, stilbenes, and flavonoids. Flavonoids represent the main polyphenolic component of citrus fruits and can be
subdivided into six further subgroups. Flavanones are particularly abundant in citrus fruits and include hesperidin as one of the major flavanones. Figure created with
BioRender.com.
growth factor receptor β (sPDGFRβ), shed from pericytes
(which unsheathe the endothelium of brain capillaries) in
response to injury, correlates with neurodegenerative disease
progression and BBB breakdown (Miners et al., 2019; Nation
et al., 2019; Montagne et al., 2020). Similarly, the ratio of CSF
albumin to serum albumin, is frequently used as an indicator
of BBB breakdown (Musaeus et al., 2020), although conflicting
results have been reported (Skillbäck et al., 2017). Less invasive
methods including measuring circulating tight junction proteins
(occludin, ZO-1 and CLDN5) have also been forwarded as BBB
breakdown measures (Jiao et al., 2015; Zhu et al., 2017), whilst
serum 14-kDa monomeric form of transthyretin (TTR) and
serum concentrations of the astrocytic protein S100B, have been
suggested as measures of BBB damage (Marchi et al., 2004).
Metabolic Function
Metabolic homeostasis is particularly important for brain health
and function due to the energy-demanding nature of the
brain. Brain energy metabolism declines subtly during the
aging process and prior to neurological disease diagnosis
(Zilberter and Zilberter, 2017), and accumulating evidence
demonstrates how this impairment of energy metabolism can
exacerbate neurodegenerative disease progression (Cunnane
et al., 2016; Camandola and Mattson, 2017). Neuroimaging
techniques can effectively indicate metabolic disturbances. For
example, FDG-PET is frequently utilized to determine brain
glucose metabolism rates across the brain, which subsequently
correlate to synaptic activity and disease risk (Shivamurthy
et al., 2015). A multitude of other positron-emitting isotope
tracers exist, including [1-11C]-DHA (Yassine et al., 2017),
and the incorporation of such tracers can hone in on specific
aspects of brain metabolism which may be disease-specific.
Furthermore, the ratio of N-acetylaspartate (NAA) and myo-
inositol (MI), two abundant metabolites in the human brain,
has been reported to be a good predictor of mild cognitive
impairment in cognitively normal older adults as measured
by 1H MRS in the posterior cingulate cortex (PCC) (Kantarci
et al., 2013). Finally, peripheral measures of metabolic function
such as insulin resistance and blood glucose, are routinely
determined in clinical trials in which cognitive health is a
primary output, and have been found to correlate with cognitive
decline (Wium-Andersen et al., 2019), and brain atrophy
(Erus et al., 2015).
Inflammatory Markers
Although neuroinflammation is an essential part of the
brain response to infection or injury (Glass et al., 2010),
sustained neuroinflammatory processes may contribute to the
progressive neuronal damage observed in aging (Barrientos
et al., 2015) and aged-related cognitive disorders (Heppner
et al., 2015; Herrero et al., 2015). As resident macrophages,
activated microglial cells have the capacity to synthesize a wide
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range of pro-inflammatory and anti-inflammatory cytokines
and molecular mediators which contribute to the systemic
inflammatory milieu and to the progression of neurodegenerative
disease (Perry and Holmes, 2014). As an integral component
of numerous neurological diseases, effective monitoring of
neuroinflammation would be highly advantageous. PET may
represent a viable option to achieve this (Chandra et al.,
2019; Kreisl et al., 2020), along with a range of markers
for activated microglia such as Translocator protein (TSPO)
radioligands showing promise both in a preclinical setting and
in humans. Optimization of TSPO tracers and identification of
more specific neuroinflammatory tracers is, however, warranted
to improve upon accuracy (Kreisl et al., 2020). Similar to
peripheral markers of metabolic function, although not a direct
marker of brain inflammation, circulating levels of the pro-
inflammatory (IL-1α, IL-1β, IL-6, TNF-α) and anti-inflammatory
cytokines (IL-1ra and IL-10) indicate a chronic inflammatory
environment and probably contribute to brain inflammation.
Again, these measures frequently correlate with measures
of brain health and disease such as cognitive performance
(Magalhães et al., 2018; Contreras et al., 2020; Ribeiro-Santos
et al., 2020).
Cognitive Testing and Sensory
Parameters
As well as biological and neuroimaging techniques, brain
health can be determined through cognitive assessment. For
this, a wide range of tests can be employed, usually in
combination as a battery, to address multiple aspects of
cognition such as memory, language, executive functions
and attention. Memory, a common target of numerous
neurodegenerative disorders, can be separated into specific
memory domains, enabling researchers to pinpoint disruptions
to specific brain systems (e.g., episodic memory; hippocampal–
diencephalic system, working memory; dorsolateral prefrontal
cortex, semantic memory; anterior temporal lobe, executive
functioning; frontal lobe and beyond) (Kipps and Hodges,
2005). Traditionally, such examination has required extensive
clinical testing, performed by trained individuals (Kipps and
Hodges, 2005), however, recent advancements in technology,
e.g., smartphones and internet-based cognitive assessment tools
may enable screening to take place outside of a clinical
setting (Coutrot et al., 2019; Hays et al., 2019; Sternin et al.,
2019).
Finally, it is worth briefly mentioning sensory parameters,
particularly olfaction, which are potentially underrated,
and certainly overlooked markers of brain health, despite
consistent reports of their predictive capacity in cognitive decline
(Brai et al., 2020).
BIOAVAILABILITY OF CITRUS
FLAVONOIDS
The extent to which citrus flavanones may exert their biological
action is strongly related to their bioavailability which can
be affected by many factors including the structure of the
compound, the food matrix, or host factors (age, sex, genetic
polymorphism, gut microbiota etc.) (Kay et al., 2017; Morand
and Tomás-Barberán, 2019). There is an apparent difference
between the absorption of glycosides and aglycones with the
glycosylation of flavanones increasing their hydrophilicity
therefore abolishing passive diffusion and thus lowering their
bioavailability (Najmanová et al., 2019). For example, following
oral administration of hesperidin, plasma concentrations of
flavanone conjugates (e.g., hesperetin-glucuronides and sulfo-
glucuronides) were detected after 3 h and reached a peak
between 5 h and 7 h (Manach et al., 2003), highlighting that
the main site for flavanone absorption is the small intestine
and the colon. Such results were further confirmed by a more
recent study where fasted participants, aged 51–69 years,
received either orange juice or a hesperidin supplement
(both providing 320 mg hesperidin) versus a control (all
matched for sugars and vitamin C content). Total plasma
flavanone metabolite concentrations were significantly higher
5 h after the orange juice intervention than after control with
hesperidin-glucuronide and naringenin-7-O-glucuronide,
largely contributing to the total plasma flavanone concentration.
Unexpectedly, no significant concentration of hesperidin
metabolites was observed at 5 h following the hesperidin
supplement intake, which may highlight the importance of
food matrix in the bioavailability of these compounds (Schär
et al., 2015). In addition to the main phase II metabolites
found in the systemic circulation, the intestinal microflora
further degrades aglycones into smaller phenolics. For
example, the main degradation product of hesperetin is
3-(3′-hydroxy-4′-methoxyphenyl)propionic acid, although
many other compounds have also been reported (see Kay
et al., 2017; Najmanová et al., 2019 for extensive reviews of
flavanones metabolism).
Flavanone bioavailability can differ across citrus source
and/or form. For example, the bioavailability of hesperidin,
indirectly determined from excreted hesperetin (main hesperidin
metabolite marker) is comparable for both whole orange
fruit (1.5%) and orange juice (2.9%), despite the considerably
higher flavanone content of the fruit (Aschoff et al., 2016),
reflecting potential absorption and metabolic differences. Fresh
and packaged orange juice, on the other hand, appear to have
relatively similar metabolic kinetics in regards to flavanones,
and therefore the higher flavanone content found in packaged
juice (machine pressed) translates to a threefold greater flavanone
status (Silveira et al., 2014).
In addition, a large inter-individual variability in the
bioavailability of citrus flavanones has been reported with high,
medium, and low flavanone metabolite excreters identified
following intake of citrus flavanones and citrus juices (Nielsen
et al., 2006; Brett et al., 2008; Vallejo et al., 2010; Aschoff et al.,
2016). One of the key factors in this variability may reside
in the host–microbiota diversity necessary for the conversion
of the flavanone rutinoside into their aglycone forms (Stevens
et al., 2019), although the impact of lifestyle factors such as
exercise have also been reported (Pereira-Caro et al., 2017).
Despite the demonstrated high inter-individual variability in
citrus flavanones metabolism, limited evidence is currently
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available regarding the role of the gut microbiota composition
and no correlation with the effects on brain health biomarkers
has been demonstrated.
When considering the bioavailability of citrus flavonoids
from a neurological perspective, one must also consider the
compounds ability to traverse the BBB. The extent to which
specific citrus polyphenols cross the BBB remains to be
fully categorized, however, evidence to date in the form of
in vitro cellular models (e.g., RBE4, b.END5, and hCMEC/D3)
(Youdim et al., 2003; Yang W. et al., 2014), and preclinical
approaches (Peng et al., 1998; Tsai and Chen, 2000; Youdim
et al., 2004) indicate that citrus flavonoids, namely; hesperetin,
naringenin, as well as their relevant metabolites, are able to
reach the brain. Whether these models fully translate to humans,
particularly when ingested with other complex food sources
is yet to be proven, however, pursuing this question will
undoubtedly enhance our understanding of citrus polyphenols
in the context of brain health and disease, elucidating the extent
to which their bioactivity stems from direct interaction with the
brain parenchyma.
MICROBIOTA: GUT: BRAIN AXIS
A healthy gastrointestinal tract is a nutrient-rich environment
hosting approximately 100 trillion microbes (Lin and Zhang,
2017), that constitute the gut microbiota. Gut microbial
composition is increasingly recognized as a central factor in
health and disease, protecting the intestinal gut barrier and
preventing the establishment of pathogenic microorganisms.
The gut microbiota also provides a large repertoire of genes,
antigens and metabolites that can regulate immune and metabolic
functions. The gut-brain axis describes a bidirectional system
that encompasses both neuro-immune (Teratani et al., 2020)
and neuro-endocrine communication as well as a direct
neuronal connection (vagus nerve) (Tan et al., 2020), with
each mode of transmission receiving microbial modulation
(Lv et al., 2019; Wang et al., 2019). The gut-brain axis
has rapidly emerged in recent decades, with an influx of
literature implicating gut health and microbial dysbiosis with
specific neurological diseases/conditions, although the multi-
factorial nature and complexity of these diseases/conditions
has left mechanistic validation somewhat lagging (Sherwin
et al., 2018). Indeed, further elucidation of the mechanistic as
well as the determination of overall therapeutic validity are
still required (Peterson, 2020). An area in which mechanistic
evidence is beginning to gain traction is the synthesis
and/or regulation of metabolites by the gut-microbiota, with
many derivative metabolites established as neurochemicals or
possessing neuromodulatory properties. Short-chain fatty acids
(SCFA) are a relatively well-characterized example of this (Dalile
et al., 2019) and are produced via fermentation of complex
carbohydrates (dietary fibers). SCFA levels are diminished
in response to antibiotic treatment (Høverstad et al., 1986)
and similarly low levels tend to associate with conditions
such as depression, Alzheimer’s (AD) and Parkinson’s disease
(Dalile et al., 2019). For example, the SCFA propionate was
recently reported to inhibit pathways associated with non-
specific microbial infections via a CD14-dependent mechanism,
to suppress the expression of LRP-1 and to protect the BBB
from oxidative stress via NRF2 (NFE2L2) signaling (Hoyles et al.,
2018). The influence of metabolites such as SCFA produced by
our ‘gut-biofactory’ has been extensively reviewed by Skonieczna-
Żydecka et al. (2020).
The considerable inter-individual variability of the gut
microbiota combined with its apparent modifiable/dynamic
nature has led to it being identified as a therapeutic target.
The fact that beneficial shifts could be achieved through non-
invasive, relatively safe interventions, e.g., prebiotics, make it
an attractive target. The gut microbiota is both modulated
by, and modulates, polyphenolic compounds (Koudoufio et al.,
2020). Citrus polyphenols appear to be no exception, with
neohesperidin recently shown to reverse high-fat-diet-induced
intestinal microbiota dysbiosis by increasing general microbial
diversity as well as specific strains including Bacteroidetes and
Firmicutes (Lu et al., 2020). A similar experiment in which
hesperidin was administered exerted similar prebiotic effects
with treated mice displaying improved metabolic maker profile
(Guirro et al., 2020). These beneficial hesperidin mediated effects
are in agreement with an earlier experiment, which interestingly
reported upon the concomitant immunomodulatory actions
(Estruel-Amades et al., 2019). In healthy volunteers, continuous
consumption of commercial pasteurized orange juice for
2 months improved blood biochemical parameters, such as low-
density lipoprotein-cholesterol, glucose, and insulin sensitivity
and positively modulated the composition and metabolic
activity of the microbiota, increasing the population of fecal
Bifidobacterium spp. and Lactobacillus spp. (Lima et al., 2019).
In addition, daily consumption of 500 mL of two Brazilian
orange juices (e.g., Cara Cara and Bahia juices) for 7 days
increased the abundance of Mogibacteriaceae, Tissierellaceae,
Veillonellaceae, Odoribacteraceae, and Ruminococcaceae families
in healthy volunteers (Brasili et al., 2019). Furthermore, daily
consumption of 300 ml of orange juice for 60 days affected the
levels of Lactobacillus spp., Akkermansia spp., and Ruminococcus
spp. and improved the glycemia and lipid profiles in 20–35 years
old healthy female volunteers (Fidélix et al., 2020). These recent
reports emphasize the prebiotic potential of citrus polyphenols,
particularly in metabolic disease, with no specific information
related to brain functions (e.g., gut-brain axis). With this being
said, it must be mentioned that current evidence has been
predominantly provided through preclinical and in particular,
rodent experiments. Therefore, current perspectives derived from
these studies should be cautiously interpreted until validated
through robust clinical trials since fundamental human to mouse
differences, such as microbial composition and gut physiology,
may render direct translation inappropriate.
METHOD
A non-systematic search was performed in PubMed using
the following keywords to retrieve preclinical and clinical
data: [(Dementia OR depression OR Alzheimer OR Parkinson
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OR neurodegeneration OR neuroinflammation) AND (citrus
polyphenol OR flavanone OR hesper∗ OR naring∗) AND
(cognition OR brain)]. Articles in English or with English
abstracts were retrieved. All evidence was read and chosen
based on the Authors’ evaluation of relevance. The search was
concluded in August 2020 and updated in November 2020, and
included all articles present in PubMed, without temporal limits.
PRECLINICAL EVIDENCE FOR CITRUS
FLAVONOIDS AND BRAIN
HEALTH/FUNCTION
Neurodegeneration describes a process of progressive cell
dysfunction and eventual neuronal cell death. In diseases
such as late-onset Alzheimer’s Disease (LOAD) this process
can span decades. Although usually categorized based upon
distinct pathologies, the overall process of neurodegeneration
is one that is multi-factorial, with many neurodegenerative
diseases sharing common pathogenic mechanisms underpinning
disease progression (Jellinger, 2010), potentially explaining
the lack of efficacy of single target drugs. These common
mechanisms associated with neurodegeneration include:
neuroinflammatory/neuroimmune responses, oxidative
stress, impaired bioenergetics/mitochondrial dysfunctions,
dysfunction of neurotrophins and abnormal protein dynamics.
The mechanistic understanding of citrus polyphenols in
brain health stems largely from preclinical and in vitro
studies. The focus of these preclinical studies often centers
on mitigating specific disease pathologies. Indeed, a wealth
of preclinical evidence has highlighted the multifaceted
nature of citrus polyphenols neurologically. Interestingly, as
highlighted in Table 1, the major citrus polyphenols share
common mechanistic actions, overlapping considerably with the
aforementioned deficits associated with neurodegeneration.
Below we discuss these mechanisms in more details
focusing on the key citrus flavonoids and in particular on
the flavanones hesperidin and naringin along with their
aglycone forms (i.e., hesperetin and naringenin) and the
flavonol, kaempferol.
Anti-oxidative
Oxidative stress is a well-established contributing factor in
neurological disorders (Michalska and León, 2020) with high
metabolic activity combined with a lack of antioxidant defense
capability leaving the brain particularly susceptible. Although
citrus polyphenols reportedly demonstrate free radical scavenger
capacity in vitro (Di Meo et al., 2013), the current literature
search unanimously highlighted their ability to stimulate the
endogenous antioxidant defense machinery, with superoxide
dismutase (SOD), catalase (CAT), glutathione (GSH), glutathione
S-transferases (GST), glutathione reductase (GR) and glutathione
peroxidase (GPx) activation common across all the citrus
polyphenols reviewed (Table 1). Effective dosage ranged
from as little as 5 mg/kg up to 300 mg/kg, however,
dose dependant effects were established in a number of
studies, with greater doses usually eliciting greatest effects
(Table 1). Activation coincided with subsequent reduction of
reactive oxygen species (ROS) such as hydrogen peroxide
(H2O2), nitric oxide (NO) and other oxidative markers
namely malondialdehyde (MDA) and thiobarbituric acid reactive
substances (TBARS). Upregulation of the transcription factor
NRF2 features in a number of these studies (Bai et al.,
2014; Sugumar et al., 2019; Welbat et al., 2020), and is
likely central to this polyphenol mediated anti-oxidative system
through the activation of the antioxidant response element
(Vauzour, 2012). As alluded to, activation of the antioxidant
defense machinery was generally consistent across the flavonoids
with only a few discrepancies found, mainly confined to
naringenin and hesperetin, where occasionally no effect was
detected (Chtourou et al., 2014; Kheradmand et al., 2018;
Mani et al., 2018). A few studies reported the opposite effect
for naringenin with SOD and CAT reduced (Chtourou et al.,
2014; Haider et al., 2020). This reduction associated with
naringenin, which is believed to be able to cross the BBB
(Youdim et al., 2003), may relate back to its free radical
scavenging capabilities, or arise as a result of the differing disease
models used. In addition to the more common antioxidant
machinery influenced, hesperidin and hesperetin upregulated
Haem-oxygenase (HO-1) and downregulated the superoxide
radical generating enzyme Xanthine Oxidase (XO) respectively
(Ashafaq et al., 2014).
Anti-inflammatory
The immunomodulatory capabilities of citrus polyphenols within
the brain are similarly evident, and are in some cases coupled to
anti-oxidative mechanisms (e.g., HMGB1/RAGE, Yu et al., 2015).
Again, the molecular targets with which the reviewed citrus
polyphenols interact appear to be consistent, with reduction of
pro-inflammatory cytokines IL-1β, IL-2, IL-6, IFN-γ, and TNF-α,
particularly prolific in the literature (Table 1). This is likely
mediated through the mitigation of hyperactive immune cells
as is suggested by the reduction of GFAP, and NF-κB which
governs chemokine and inflammatory mediator transcription
(Fu et al., 2019; Zhou et al., 2020). In contrast to evidence on
anti-oxidative effects, there was little indication to suggest lack
of effect across any of the reviewed flavonoids, supporting the
notion that neuro-inflammatory modulation is inherent across
all citrus flavonoids. As with anti-oxidative effects, effective
dosage had a considerable range of 20–300 mg/kg, with efficacy
remaining even at lower doses 25–50 mg/kg. This latter dose
equates to 145–290 mg human equivalent dose in a 70 Kg
adult, if the animal is a mouse (Nair and Jacob, 2016), which is
achievable through consumption of 0.5–0.75 L of orange juice
(De Rycker et al., 2020).
Bioenergetic
Citrus flavonoids appear to ameliorate mitochondrial
dysfunction – damage to the mitochondria which may be due
to exogenous factors and which can predispose individuals to
certain neurodegenerative conditions. As with anti-inflammatory
properties, the impact was consistent across the reviewed
studies with reported dosages of 25–200 mg/kg resulting in
an increase of mitochondrial respiratory chain complexes
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TABLE 1 | Overview of the molecular mechanisms underlying the impact of citrus flavonoids on brain health and disease in preclinical models.
Citrus
Polyphenol






↓NF-κB, ↓TNF-α, ↓ IL-1β 100, 200 (15 days)
Dose dependant with
200 more effective
Sodium arsenite treatment, 10-week-old
male Sprague-Dawley rat (Kuzu et al.,
2020)
↓TNF-α, ↓IFNγ, ↓IL-1β, ↓IL-2, ↓IL-6, ↑IL-10 50 (28 days) Intrastriatal injection 6-OHD, 3–6-month
adult male C57BL/6 mouse (Antunes et al.,
2020)
↓TNF-α, ↓IL-1β, ↓IL-6, ↓HMGB1, ↓RAGE, ↓p-NFκB,
↓p-IκBa
100 and 200 (three
times a week for
3 weeks)
Chronic unpredictable mild stress,
6–8-week ICR male mouse (Fu et al., 2019)
↓IL-1β, ↓TNF-α 50(14 days) Concussive head injury, 10–11-week male
NMRI mouse (Kosari-Nasab et al., 2018)
↓IL-1β, ↓IL-6 50 (14 days) Olfactory bulbectomy, male C57BL/6
mouse (Antunes et al., 2016)
↓IL-1β, ↓IL-6, ↓TNF-α, ↑miRNA132 25, 50, 100 (7 days) I.P. LPS, male ICR mouse (Li M. et al.,
2016)
↓Iba-1, ↓TGF-β 100 (10 days) Transgenic APP/PS1, 5-month male mouse
(Li et al., 2015)
↓GFAP, ↓iNOS, ↓NF-κB, ↓COX-2 (No quantification) 100 and 200 (15 days) Swiss male albino mouse (Javed et al.,
2015)
↓IL-6 25, 50, and 100
(21 days)
I.P. STZ, male albino Wistar rat (El-Marasy
et al., 2014)
↓IL-1β, ↓TNF-α, ↓GFAP, ↓iNOS 50 (15 days) Middle cerebral artery occluded, 16-week
male Wistar rat (Raza et al., 2011)
Anti-oxidative ↓MDA, ↓8-OHdG, ↑GSH, ↑GPx, ↑SOD, ↑CAT 100, 200 (15 days)
Dose dependant with
200 more effective
Sodium arsenite treatment, 10-week-old
male Sprague-Dawley rat (Kuzu et al.,
2020)
↑Glo1, ↓AGE, ↓ROS, ↓MDA, ↑GSH, ↑SOD, ↑Nrf2,
↑γ-GCS
50, 150 (10 weeks)
Dose dependant with
150 more effective
I.P. STZ, adult male Sprague Dawley rat
(Zhu et al., 2020)
↑Nrf2, ↓MDA, ↑SOD activity, ↑GPx activity, ↑CAT
activity
100 (21 days) IV injection Methotrexate, 4–5 weeks male
Sprague Dawley rat (Welbat et al., 2020)
↓MDA, ↓NO, ↑GSH, ↑GSH-Px, ↑SOD, ↑CAT 10 (21 days) Acrylamide treated, adult male Wistar
albino rat (Elhelaly et al., 2019)
↓MDA 50↑(14 days) Concussive head injury, 10–11-week male
NMRI mouse (Kosari-Nasab et al., 2018)
↑MDA, ↓GSH, ↓SOD, ↓CAT 25, 50, 100 (14 days)
Dose dependant with
100 more effective
L-Methionine treated, male Wistar rat
(Hemanth Kumar et al., 2017)
↓TBARS, ↑GSH, ↑SOD, ↑CAT, ↑GPx 100 (60 days) I.P. AlCl3, 10–12-week male albino Wistar
rat (Justin Thenmozhi et al., 2017)




12-month Swiss male albino mouse (Javed
et al., 2015)
↓MDA, (↑GSH did not increase in 100 group) 25, 50, and 100
(21 days)
I.P. STZ, male albino Wistar rat (El-Marasy
et al., 2014)
↓H2O2, ↓MDA, ↑GSH, ↑T-AOC 100 (16 weeks) APPswe/PS1dE9, 3-month-old male
mouse (Wang et al., 2014)
↓ROS, ↑GPx, ↑GSH, ↑TRAP, ↑CAT, ↑GPx, ↓GR (SOD
and GST no change)
50 (28 days) Intracerebroventricular injection of 6-OHDA,
female C57BL/6 mouse (Antunes et al.,
2014)
↓TBARS, ↑NP-SH, ↑GSH, ↑GST, ↑GR, ↓XO 50 (28 days) I.P. STZ, male Wistar rat (Ashafaq et al.,
2014)
↓TBARS, ↑GPx, ↑SOD, ↑CAT 50 (15 days) Middle cerebral artery occluded, 16-week
male Wistar rat (Raza et al., 2011)
Anti-Apoptotic/
Proliferative
↓Caspase-3 100, 200 (15 days)
Dose dependant with
200 more effective
Sodium arsenite treatment, 10-week-old
male Sprague-Dawley rat (Kuzu et al.,
2020)
(Continued)
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↑BDNF, ↓p21 positive cells, ↑DCX 100 (21 days) I.V injection Methotrexate, male Sprague
Dawley rat (Welbat et al., 2020)
↑BDNF, ↑NGF, ↑NT3 50 (28 days) Intrastriatal injection 6-OHD, 3–6-month
adult male C57BL/6 mouse (Antunes et al.,
2020)
↑Ki-67, ↑BrdU, ↑DCX 100 (21 days) IV injection Methotrexate, male Sprague
Dawley rat (Naewla et al., 2019)
↑BDNF, ↑p-TrkB 100, 200 (3x in
21 days)
Chronic unpredictable mild stress,
6–8-week male ICR mouse (Fu et al., 2019)
↑BDNF 100 and 200 (21 days) Concussive head injury, 10–11-week male
NMRI mouse (Kosari-Nasab et al., 2018)
↑BDNF, ↑NGF 50 (14 days) Olfactory bulbectomy, male C57BL/6
mouse (Antunes et al., 2016)
↓BAX, ↑BCL-2 100 (60 days) IP AlCl3, 10–12-week male albino Wistar
rat (Justin Thenmozhi et al., 2017)
↑p-ERK, ↑BDNF (ERK dependent) 25, 50 (3 weeks) Chronic mild stress, 5-week male ICR
mouse (Li C. F. et al., 2016)
↑BDNF 25, 50, and 100
(21 days)
I.P. STZ, male albino Wistar rat (El-Marasy
et al., 2014)
Bioenergetic ↓AChE 100, 200 (15 days)
Dose dependant with
200 more effective
Sodium arsenite treatment, 10-week-old
male Sprague-Dawley rat (Kuzu et al.,
2020)
↓AChE 50 (14 days) Olfactory bulbectomy, male C57BL/6
mouse (Antunes et al., 2016)
↓AChE activity 100 and 200 (15 days) Intracerebroventricular injection STZ,
12-month Swiss male albino mouse (Javed
et al., 2015)
↑ MT complex (I-IV) activity, ↑MTT activity, ↑GSK3b
phos
100 (16 weeks) APPswe/PS1dE9, 3-month-old male
mouse (Wang et al., 2014)
↓AChE, ↑Na + -K + ATPase 50 (28 days) I.P. STZ, male Wistar rat (Ashafaq et al.,
2014)
Proteinopathy ↓Aβ deposition 100 (10 days) Transgenic APP/PS1–21, 5-month male
mouse (Li et al., 2015)
No change Aβ deposition 100 (16 weeks) Three-month-old male, APPswe/PS1dE9
mouse (Wang et al., 2014)
BBB
dysfunction
↓EB leakage, ↓claudin-5 and ZO-1 disturbance 10 (1 dose prior to
MCAO)
Left middle cerebral artery occlusion, male
8 weeks ICR mouse (Lee et al., 2020)
Hesperetin Anti-
inflammatory
↓TLR4, ↓GFAP, ↓Iba-1, ↓TNF-α, ↓IL-1β, ↓p-NF-κB 50 (5 weeks) I.P. LPS, 7/8 weeks male C57BL/6N mouse
(Muhammad et al., 2019)
↓TNF-a, ↓IL-1b, ↓iNOS 20 (8 days) Hippocampal injection Kainic Acid, mouse
(Kwon et al., 2018)
↓GFAP, ↓NF-κB 50 (1 week) Intrastriatal injection 6-OHDA, male adult
Wistar rat (Kiasalari et al., 2016)
Anti-oxidative ↓MDA, ↑GSH, ↑SOD, ↑CAT (50 only), ↓NO (50 only) 5, 50 (3 days) I.P. scopolamine, male albino mouse (Ishola
et al., 2019)
↑Nrf-2, ↑HO-1 ↓ROS, ↓LPO 50 (5 weeks) I.P. LPS, 7–8-week male C57BL/6N mouse
(Muhammad et al., 2019)
↓MDA, (GSH, CAT, SOD, GPx, GRx No change)
(however effect significant in Nano form)
10, 20 (3 weeks) I.P. injection STZ, male Wistar rat
(Kheradmand et al., 2018)
↓TBARS, ↓LOOH and ↓Protein carbonyl content (LPO),
↓ OH-, ↓NO, ↑GSH, ↑TSH, ↑SOD, ↑CAT, ↑GPx and
↑GST
40 (21 days) Subcutaneous injection of Cadmium, male
albino Wistar rat (Shagirtha et al., 2017)
↓MDA, ↑CAT, ↑GSH, (NO No change) 50 (1 week) Intrastriatal injection of 6-OHDA, male adult
Wistar rat (Kiasalari et al., 2016)
Anti-Apoptotic/
Proliferative
↑BDNF 5, 50 (3 days) I.P. scopolamine, male albino mouse (Ishola
et al., 2019)
↓p-JNK, ↓Bax:Bcl2, ↓Caspase-3 50 (5 weeks) I.P. LPS 7-8-week, male C57BL/6N mouse
(Muhammad et al., 2019)
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↓Bax, ↓cytochrome c, ↓caspase 3 and 9, ↑Bcl2 40 (21 days) Subcutaneous injection of Cadmium, male
albino Wistar rat (Shagirtha et al., 2017)
↑Bcl2, ↓DNA fragmentation 50 (1 week) Intrastriatal injection of 6-OHDA, male adult
Wistar rat (Kiasalari et al., 2016)
Bioenergetic ↓AChE 5, 50 (3 days) I.P. scopolamine, male albino mouse (Ishola
et al., 2019)
↑AChE, ↑ATPases, ↑ MT complex (I-IV) activity 40 (21 days) Subcutaneous injection of Cadmium, male
albino Wistar rat (Shagirtha et al., 2017)
Proteinopathy ↑Cathepsin, trypsin and pronase activity 40 (21 days) Subcutaneous injection of Cadmium, male
albino Wistar rat (Shagirtha et al., 2017)
Naringenin Anti-
inflammatory
↓GFAP, ↓TNF−α, ↓IL−1β, ↑IL10 250–300 (10 weeks) High-fat diet-fed, 10-month SAMP8 male
mouse (Zhou et al., 2020)
↓iNOS 25, 50, 100 (5 days) I.P. MPTP, male C57BL/6J mouse
(Sugumar et al., 2019)
↓IL−6, ↓TNF−α, ↓NFκB, ↓IFN-γ 50, 100 (14 days) Bilateral olfactory bulbectomy, 3-month
BALB/c male mouse (Bansal et al., 2018)
↓NFκB, ↓TNFα, ↓COX2, ↓iNOS, ↓TLR4, ↓GFAP 100 (7 days) I.P. LPS, male albino Wistar rat
(Khajevand-Khazaei et al., 2018)
↓IL−1β, ↓TNF−α (not 25 mg/kg) 25, 50, 100 (5 days) I.P. MPTP, male C57BL/6J mouse (Mani
et al., 2018)
↓NFκB, ↓iNOS, ↓COX2, ↓TNF−α, ↓IL−1β 50 (21 days) Middle cerebral artery occlusion, 16-week
male Wistar rat (Raza et al., 2013)
Anti-oxidative ↑SOD, ↑GSH, ↓MDA, ↓NO 250–300 (10 weeks) High-fat diet-fed, 10 months SAMP8 male
mouse (Zhou et al., 2020)
↓SOD activity, ↑CAT, ↑GPx,↑GSH, ↓MDA 50 (14 days) I.P. AlCl3 + D-gal injection, young albino
Wistar rat (Haider et al., 2020)
↑GSH, ↑GST, ↓MDA, ↓Protein carbonyl content 100 (15 days) Oral MeHg, 5-week male Swiss albino
mouse (Krishna Chandran et al., 2019)
↓LPO, ↑CAT, ↑GR 25, 50, 100 (5 days) I.P. MPTP, male C57BL/6J mouse
(Sugumar et al., 2019)
↑SOD, ↑GSH, ↑CAT, ↓MDA, ↓NO 50, 100 (14 days) Bilateral olfactory bulbectomy, 3-month
BALB/c male mouse (Bansal et al., 2018)
↑Nrf2, ↑CAT, ↑SOD, ↑GSH, ↓MDA 100 (7 days) I.P. LPS, male albino Wistar rat
(Khajevand-Khazaei et al., 2018)
↑SOD, (↑GSH not significant), (↓NO 100 mg/kg not
significant)
25,50,100 (5 days) I.P. injection MPTP, male C57BL/6J mouse
(Mani et al., 2018)
↑CAT, ↑SOD, ↑GSH, ↓MDA, ↑GPx, ↓MDA 50 (16 days) Young adult male Albino Wistar rat (Liaquat
et al., 2018)
↓MDA, (SOD and NO No change) 100 (single dose) Dorsal hippocampal Aβ injection, adult male
Wistar rat (Ghofrani et al., 2015)
↓NOD2, ↓RIP2, ↓MMP-9 100 (4 days) Permanent middle cerebral artery
occlusion, male Sprague–Dawley rats (Bai
et al., 2014)
↓ROS, ↓NO, ↓MDA, ↓PCO, ↑ascorbic acid, ↑total thiol
groups ↓SOD, ↓CAT, (GPx No change)
50 (4 weeks) I.P. iron (Fe) injection, 10-week male Wistar
rat (Chtourou et al., 2014)
↑Nrf2 and downstream ARE genes, ↓ROS, ↑GSH 70 (4 days) Intastriatal 6-OHDA, 10-week male
C57BL/6 mouse (Lou et al., 2014)
↓TBARS, ↑GSH, ↓NO, ↓MPO activity, ↑SOD activity 50 (21 days) Middle cerebral artery occlusion, 16-week
male Wistar rat (Raza et al., 2013)
Anti-Apoptotic/
Proliferative
↑BDNF, ↑Shh 50 (5 weeks) Chronic unpredictable mild stress, adult
male Wistar rat (Tayyab et al., 2019)
↑BDNF 50, 100 (14 days) Bilateral olfactory bulbectomy, 3-month
BALB/c male mouse (Bansal et al., 2018)
↓DNA Fragmentation 100 (single dose) Dorsal hippocampal Aβ injection, adult male
Wistar rat (Ghofrani et al., 2015)
↓p-JNK, ↓p-p38 70 (4 days) Intastriatal 6-OHDA, 10-week male
C57BL/6 mouse (Lou et al., 2014)
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↑BDNF (Hippocampus) 10, 20 (3 Weeks) Chronic unpredictable mild stress, 5-week
male ICR mouse (Yi et al., 2014)
Bioenergetic ↑Ach, ↓AChE, ↓AChE activity 50 (14 days I.P. AlCl3 + D-gal injection, young albino
Wistar rat (Haider et al., 2020)
↑ MT complex (I-IV) activity, ↓MT DNA damage 100 (15 days) Oral MeHg, 5-week male Swiss albino
mouse (Krishna Chandran et al., 2019)
↓KYN:TRP ratio 50, 100 (14 days) Bilateral olfactory bulbectomy, 3-month
BALB/c male mouse (Bansal et al., 2018)
↓AChE activity 100 (7 days) I.P. LPS, male albino Wistar rat
(Khajevand-Khazaei et al., 2018)
↑Ach, ↓AChE 50 (16 days) Young adult male albino Wistar rat (Liaquat
et al., 2018)
↑Na + -K + ATPase, ↑AChE activity 50 (4 weeks) I.P. injection iron (Fe), 10 week male Wistar
rat (Chtourou et al., 2014)
↑PPARγ ↑IDE, ↑INS, ↑INSR 25, 50, 100 (21 days) Intracerebroventricular injection STZ, adult
male Sprague Dawley rat (Yang W. et al.,
2014)
Proteinopathy ↓Soluble and insoluble Aβ 40, Aβ 42, ↓APP, ↓BACE1,
↓P−tau, ↓P−GSK
250–300 (10 weeks) High-fat diet-fed, 10-month SAMP8 male
mouse (Zhou et al., 2020)
↓αSYN (100 mg/kg only), ↓αSYN + cells 25, 50, 100 (5 days) I.P. injection MPTP, male C57BL/6J mouse
(Mani et al., 2018)
↓GSK-3β, ↓pTau/Tau ratio, ↓Aβ42 25, 50, 100 (21 days) Intracerebroventricular injection STZ, adult




↓GFAP 100 (14 days) STZ treated, C57BL/6, 9-week male mouse
(Okuyama et al., 2018)
↓TNF-α, ↓IL-1β, ↓IL-6, ↓NF-kB 40 and 80↑(28 days) Intrastriatal injection of quinolinic acid, adult
male Sprague-Dawley rat (Cui et al., 2018)
↓TNF-α 20 and 40 (28 days) Intastriatal injection collagenase, adult
female Wistar rat (Singh et al., 2017)
↓NF-kB, ↓GFAP 80 (14 days) I.P. injection 3-nitropropionic acid, male
Wistar rat (Gopinath and Sudhandiran,
2016)
↓iNOS, ↓TNF-α, ↓NF-κB 25, 50 100 (5 weeks) Cisplatin exposed, middle aged Wistar rat
(Chtourou et al., 2015)
↓TNF-α, ↓IL-1β 50, 100, and 200
(21 days)
Intracerebroventricular STZ, adult male
Wistar rat (Sachdeva et al., 2014)
Anti-oxidative ↑SOD, ↑GSH, ↓MDA, ↓NO 40 and 80 (28 days) Intrastriatal injection quinolinic acid, adult
male Sprague-Dawley rat (Cui et al., 2018)
↓MDA (reduced by 10 mg/kg also), ↑CAT, ↑GSH,
↑SOD (40 mg/kg only), ↓NO
20 and 40 (28 days) Intastriatal injection collagenase, adult
female Wistar rat (Singh et al., 2017)
↓MDA, ↓PCO, ↓H2O2, ↓ROS, ↓NO (50 and 100 only),
↑SOD, ↑CAT, ↑GSH, ↑GPx
25, 50, and 100
(5 weeks)
Cisplatin exposed, middle aged Wistar rat
(Chtourou et al., 2015)
↓ROS 100 (20 weeks) High-fat diet induced cognitive decline,
male C57BL/6 mouse (Wang et al., 2015b)
↓MDA, ↓NO, ↑GSH, ↑SOD, ↑CAT 50, 100, and 200
(21 days)
Intracerebroventricular STZ, adult male
Wistar rat (Sachdeva et al., 2014)
Anti-Apoptotic/
Proliferative
↑DCX 100 (14 days) STZ treated, C57BL/6 male (9-week)
mouse (Okuyama et al., 2018)
↓Bax, ↑Bcl-2, ↓Caspase-3, ↑PPAR-γ 40 and 80 (28 days) Intrastriatal injection of quinolinic acid, adult
male Sprague-Dawley rat (Cui et al., 2018)
Bioenergetic ↑MT complex (I-IV) 40 and 80 (28 days) Intrastriatal injection of quinolinic acid, adult
male Sprague-Dawley rat (Cui et al., 2018)
↓AChE activity, ↑Na + -K + ATPase, ↑Ca2 + ATPase,
↑Mg2 + ATPase (increased by 25 mg/kg also)
50 and 100 (5 weeks) Cisplatin exposed, middle aged Wistar rat
(Chtourou et al., 2015)
↑MT membrane potential, ↑ATP levels, ↑AMPK 100 (20 weeks) High-fat diet induced cognitive decline,
male C57BL/6 mouse (Wang et al., 2015b)
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↓AChE activity, ↑MT complex (I-IV) activity 50, 100, and 200
(21 days)
Intracerebroventricular STZ, adult male
Wistar rat (Sachdeva et al., 2014)
Proteinopathy ↓Thr231 and Ser396 Tau phos 100 (14 days) STZ treated, C57BL/6 male (9-week)
mouse (Okuyama et al., 2018)
Kaempferol Anti-
inflammatory
↓Iba-1, ↓TNFα, ↓IL-1β, ↓IL-5, ↓IL-6, ↓iNOS, ↓COX-2,
↓NF-κB
25, 50, 100 (7 days)
Dose dependant 100
most effective
Cerebral ischemia/reperfusion, rat (Li et al.,
2019)
↓Iba-1, ↓IL-1β, ↓IL-6, ↓TNFα, ↓MCP-1, ↓ICAM-1,
↓COX-2, ↓HMGB1, ↓TLR4
20 and 50 (7 days)
Dose dependant 50
most effective
I.P. LPS, adult male BALB/c mouse (Yang
et al., 2019)
↓Iba1, ↓IL-1β, ↓IL-6, ↓TNF-α, ↓MCP-1, ↓COX-2,
↓iNOS, ↓HMGB1, ↓TLR4, ↓MyD88
25, 50, or 100 (7 days) I.P. LPS, adult male BALB/c mouse (Cheng
et al., 2018)
↓TNF-α 10 (21 days) Intracerebroventricular injection STZ, OVX
female Wistar rat (Kouhestani et al., 2018)
Anti-oxidative ↑SOD, ↑GSH, ↓MDA 10 (21 days) Intracerebroventricular injection STZ, OVX
female Wistar rat (Kouhestani et al., 2018)
↓MDA, ↑GPx, ↑CAT, ↑SOD, ↑GSK3β – Nrf2 21 (14 days) I.P. Chlorpyrifos daily for 14 days, 8-week
male albino Wistar rat (Hussein et al., 2018)
Bioenergetic ↑AChE activity 21 (14 days) I.P. Chlorpyrifos daily for 14 days, 8-week
male albino Wistar rat (Hussein et al., 2018)
↑TCA cycle flux, ↓acyl carnitines, ↑N-acetyl aspartate 1 (three times: 1, 24,
48 h)
Traumatic Brain Injury, 23–24-day male
Wistar rat (Chitturi et al., 2019)
BBB protection ↓EB leakage, ↓MMP-3 25, 50, 100 (7 days)
Dose dependant 100
most effective
Cerebral ischemia/reperfusion, rat (Li et al.,
2019)
↓ultrastructure destruction (electron microscope),
↑occludin, ↑claudin-1, ↑CX-43
20 and 50 (7 days)
Dose dependant 50
most effective
I.P. LPS, adult male BALB/c mouse (Yang
et al., 2019)
↓EB leakage, ↑occludin-1, claudin-1, ↑CX43 25, 50, or 100 (7 days) I.P. LPS, adult male BALB/c mouse (Cheng
et al., 2018)
(I–IV) function and stability. Disturbance of mitochondria
function impairs mitochondrial enzyme bioenergetics, reducing
ATP production, while simultaneously leading to substantial
increases in ROS production thus feeding into the other
disease processes.
In addition to mitochondrial function, implications
for acetylcholinesterase activity and thus cholinergic
transmission were apparent. Generally, citrus flavonoids led
to a reduction in acetylcholinesterase activity, accompanied
by subsequent increased acetylcholine levels (Ashafaq
et al., 2014; Sachdeva et al., 2014; Chtourou et al., 2015;
Javed et al., 2015; Khajevand-Khazaei et al., 2018; Ishola
et al., 2019; Haider et al., 2020), however the reverse
(increased acetylcholinesterase activity) has was also reported
(Chtourou et al., 2014; Shagirtha et al., 2017). Again, these
discrepancies likely arise as a result of the different models
used (Table 1).
Proteinopathy
Only a limited amount of preclinical evidence exists to
support the beneficial effects of citrus on proteinopathies. This
primarily relates to Alzheimer’s disease, with reports revealing
improvements in Tau phosphorylation (Yang W. et al., 2014;
Okuyama et al., 2018; Zhou et al., 2020), and Aβ deposition
(Yang W. et al., 2014; Li et al., 2015; Zhou et al., 2020),
however no effect has also been reported (Wang et al., 2014).
The mechanistic basis for these changes remains relatively
weak, although the glycogen synthase kinase 3 beta (GSK3β)
may be a plausible candidate (Yang W. et al., 2014; Zhou
et al., 2020). A reduction of α-synuclein, the protein attributed
to parkinopathy has also been described (Mani et al., 2018),
potentially indicating that the effect extends further than
Alzheimer’s disease-associated proteins. Higher dosage appears
crucial to establish these effects, with <100 mg/kg failing
to have any impact. Finally, a report in which hesperetin
was administered demonstrated restoration of brain proteolytic
enzyme levels (Shagirtha et al., 2017), potentially linking citrus
flavonoids to lysosomal degradation processes (Aufschnaiter
et al., 2017) (Table 1).
Anti-apoptotic
Ultimately, neurodegeneration which leads to cognitive
impairment can be defined as the progressive loss of neurons.
Dysregulation of the above-mentioned processes categorically
leads to neuronal cell death. Thus, the modulation achieved
through citrus flavonoids demonstrates a switch from a
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Citrus polyphenol Behavioral test performance Reported effective Dose
(mg/kg)
Model summary/References
Hesperidin No change locomotor activity (OF), ↓anxiety-like behavior
(EPM), ↓depressive symptoms (splash test)
50 (28 days) Intrastriatal injection 6-OHD, 3–6-month adult male
C57BL/6 mouse (Antunes et al., 2020)
↓Anxiety-like behavior (EPM, OF), ↓Depressive symptoms
(FST)
50, 150 (10 weeks) Dose
dependent with 150 more
effective
I.P injection STZ, adult male Sprague Dawley rat
(Zhu et al., 2020)
↓Anhedonia (SPT), ↓Depressive symptoms (TST and FST),
↓Anxiety-like behavior (OF)
100 and 200 (three times a
week for 3 weeks)
Chronic unpredictable mild stress, 6–8-week ICR
male mouse (Fu et al., 2019)
↑Recognition memory (NOL and NOR) 100 (21 days) IV injection Methotrexate, male Sprague Dawley rat
(Naewla et al., 2019)
↓Anhedonia (SPT), ↓Depressive symptoms (TST, FST,
Novelty-suppressed feeding)
50 (14 days) Concussive head injury, 10-11-week male NMRI
mouse (Kosari-Nasab et al., 2018)
↑Spatial learning and memory (MWM and Y maze) 25, 50, 100 (14 days). Dose
dependent with 50 and 100
more effective
L-Methionine treated, male Wistar rat (Hemanth
Kumar et al., 2017)
↓Depressive symptoms (TST and FST) 100 (60 days) I.P. AlCl3, 10-12-week male albino Wistar rat (Justin
Thenmozhi et al., 2017)
↓Anxiety-like behavior (OF), ↓Depressive symptoms (FST,
rearing, grooming, splash test), ↑Spatial learning and
memory (MWM), ↑Recognition memory (NOR)
50 (14 days) Olfactory bulbectomy, male C57BL/6 mouse
(Antunes et al., 2016)
↓Anhedonia (SPT), ↓Depressive symptoms (FST), No
change OF
25, 50, 100 (7 days) I.P. LPS, male ICR mouse (Li M. et al., 2016)
↓Anhedonia (SPT), ↓Depressive symptoms (FST) 25, 50 (3 weeks) Chronic mild stress, 5-week male ICR mouse
(Li C. F. et al., 2016)
↑Social behavior (Nest building, resident-intruder assay) 100 (10 days) Transgenic APP/PS1–21, 5-month male mouse
(Li et al., 2015)
↑Spatial learning and memory (MWM) 100 and 200 (15 days) Intracerebroventricular injection STZ, 12-month
Swiss male albino mouse (Javed et al., 2015)
↓Depressive symptoms (FST) 25, 50, 100 (21 days) I.P. STZ, male albino Wistar rat (El-Marasy et al.,
2014)
↓Abnormal thigmotaxis (OF), ↑Recognition memory (NOR),
Spatial reference learning and memory (MWM)
50, 100 (16 weeks) Dose
dependent with 100 more
effective
APPswe/PS1dE9, 3-month male mouse (Wang
et al., 2014)
↓Depressive symptoms (TST), ↓Spatial memory (MWM), No
change OF
50 (28 days) Intracerebroventricular injection 6-OHDA, female
C57 BL/6 mouse (Antunes et al., 2014)
Hesperetin ↑Spatial learning and memory (MWM and Y-Maze) 50 (5 weeks) I.P. LPS, 7–8-week male C57BL/6N mouse
(Muhammad et al., 2019)
↑Recognition memory (NOR), ↑Spatial learning and
memory (MWM)
5, 50 (3 days) I.P. scopolamine, male albino mouse (Ishola et al.,
2019)
↑Recognition memory (NOR), ↑Associative memory (PAT) 10, 20 (3 weeks) I.P. STZ male Wistar rat (Kheradmand et al., 2018)
Naringenin ↑Spatial learning and memory (MWM and Barnes maze) 250-300 (10 weeks) High-fat diet-fed, 10-month SAMP8 male mouse
(Zhou et al., 2020)
↑Spatial learning and memory (MWM), ↑Recognition
memory (NOR), ↑Associative memory (PAT), ↑Working
memory (EPM), ↑Social behavior, ↓Depressive symptoms
(FST)
50 (14 days) I.P. AlCl3 + D-gal injection, young albino Wistar rat
(Haider et al., 2020)
↑Spatial learning and memory (MWM), ↑Recognition
memory (NOR)
100 (15 days) Oral MeHg, 5-week male Swiss albino mouse
(Krishna Chandran et al., 2019)
↓Anxiety-like behavior (OF), ↓Depressive symptoms (FST),
↑Spatial learning and memory (MWM)
50 (4 weeks) Chronic unpredictable mild stress, adult male
Wistar rat (Tayyab et al., 2019)
↓Anhedonia (SPT), ↓Depressive symptoms (TST and FST) 25, 50, 100 (5 days) Dose
dependent with 50 and 100
more effective
Bilateral olfactory bulbectomy, 3-month BALB/c
male mouse (Bansal et al., 2018)
↑Spatial learning and memory (Y-maze, ↑Recognition
memory (NOR), ↑Associative memory (PAT)
50, 100 (7 days) I.P. LPS male albino Wistar rat (Khajevand-Khazaei
et al., 2018)
↑Motor Function (beam walk, vertical grid, horizontal grid) 25, 50, 100 (5 days) I.P. injection MPTP, male C57BL/6J mouse (Mani
et al., 2018)
↑Spatial learning and memory (MWM) 50 (16 days) Young adult male albino Wistar rat (Liaquat et al.,
2018)
(Continued)
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TABLE 2 | Continued
Citrus polyphenol Behavioral test performance Reported effective Dose
(mg/kg)
Model summary/References
↑Spatial learning and memory (Y-maze, RAM), ↑Associative
memory (PAT)
100 (single dose) Dorsal hippocampal Aβ injection, adult male Wistar
rat (Ghofrani et al., 2015)
↓Anhedonia (SPT), ↓Anxiety (Novelty-suppressed feeding
test)
10, 20 (3 weeks) Chronic unpredictable mild stress, 5-week male
ICR mouse (Yi et al., 2014)
↑Spatial learning and memory (MWM) 25, 50, 100 (21 days) Intracerebroventricular injection, STZ adult male
Sprague Dawley rat (Yang W. et al., 2014)
↑Motor Function (Rota rod, Grip test, Adhesive-removal
test)
50 (21 days) Middle cerebral artery occlusion, 16-week male
Wistar rat (Raza et al., 2013)
Naringin ↑Locomotor activity (Rotarod, Beam-crossing, footprint
analyses), ↓Depressive symptoms (Grooming)
40 and 80↑(28 days) Intrastriatal injection quinolinic acid, adult male
Sprague-Dawley rat (Cui et al., 2018)
↑Motor/locomotor activity (Horizontal Bar, Spontaneous
Motility, Forelimb Flexion, Righting Reflex, Actophotometer,
Rotarod, Paw withdrawal) ↓Depressive symptoms (FST)
↑Spatial learning and memory (MWM)
20 and 40 (28 days) Dose
dependent 40 most
effective
Intastriatal injection collagenase, adult female
Wistar rat (Singh et al., 2017)
↓Motor abnormalities (Hind limb function test, Grip strength
test, Print length analysis)
80 (14 days) I.P. 3-nitropropionic acid, male Wistar rat (Gopinath
and Sudhandiran, 2016)
↑Spatial learning and memory (MWM), ↑Recognition
memory (NOR)
100 (20 weeks) High-fat diet induced cognitive decline, male
C57BL/6 mouse (Wang et al., 2015b)
↓Anxiety-like behavior (OF, elevated T maze) 25, 50, 100 (5 weeks) Dose
dependent with 100 most
effective
Cisplatin exposed, middle aged Wistar rat
(Chtourou et al., 2015)
↑Spatial learning and memory (MWM) ↑Working memory
(EPM)
50, 100, and 200 (21 days) Intracerebroventricular STZ, adult male Wistar rats
(Sachdeva et al., 2014)
Kaempferol ↑Sensorimotor behaviors (Whisker stimulation-induced
motor response, Forelimb usage test)
1 (three times: 1, 24, 48 h) Traumatic Brain Injury, 23–24-day male
Sprague-Dawley rat (Chitturi et al., 2019)
↑Spatial learning and memory (Y-maze), ↑Recognition
memory (NOR)
21 (14 days) I.P. Chlorpyrifos daily for 14 days, 8-week male
albino Wistar rat (Hussein et al., 2018)
↑Spatial learning and memory (MWM) 10 (21 days) Intracerebroventricular injection STZ, OVX female
Wistar rats (Kouhestani et al., 2018)
disease state to an overall anti-apoptotic environment and in
some cases an additional increase proliferation/neurogenesis.
Amongst markers of these effects, the nuclear protein Ki67
and the microtubule-associated protein doublecortin (DCX)
were reported in addition to the apoptotic regulating proteins
Bax-Bcl2, and ERK-BDNF (Table 1).
Cognitive Outcomes
Unsurprisingly, given the established effects of flavonoids on
key markers of brain health and functionality at molecular and
metabolic levels, in studies where cognition was determined,
flavonoid supplementation led to improvements in cognitive
performance. Cognitive and behavioral assessment further
supports/demonstrates the neuroprotective properties associated
with citrus flavonoids (Table 2). Anxiolytic and antidepressant
actions were particularly prominent across the literature and
appeared to be consistent across several disease models,
suggesting modulation of a fundamental anxiety and depression
related process. Similarly, citrus polyphenol supplementation
improved deficits in learning and memory, specifically spatial
and recognition memory, which may indicate protection of
medial temporal lobe, particularly vulnerable to Alzheimer’s like
neurodegenerative diseases. Improvements in motor functions
and locomotion were also apparent, and impressively remained
even in most severe models such as middle cerebral artery
occlusion (Raza et al., 2013), and traumatic brain injury
(Chitturi et al., 2019).
HUMAN EVIDENCE FOR CITRUS
POLYPHENOLS AND BRAIN HEALTH
Whilst a wealth of pre-clinical (reviewed above) and in vitro
data exploring neurocognitive outcomes in relation to citrus
flavonoids is currently available, the same cannot be said for
human trials which remain considerably limited in number.
In our literature search, we identified 10 human studies (five
observational; five interventions) assessing the effects of citrus
flavonoids on brain health and cognition in healthy adults, or in
addition to other co-morbidities including depression, dementia,
schizophrenia, and stroke.
Studies on Healthy Adults
The benefits of citrus fruit consumption in the context of healthy
aging were highlighted by a cross-sectional study involving 2031
elderly (aged 70–74 years) Norwegian individuals which explored
the impact of different plant foods on cognitive performance
(Nurk et al., 2010). Study participants underwent extensive
cognitive testing in addition to completing comprehensive
food frequency questionnaires. After adjustment for multiple
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TABLE 3 | Overview of intervention studies on citrus fruits in brain health and disease in humans.









N/A (Healthy adults) High flavanone drink
(70.5 mg)
Acute




N/A (Healthy adults) Flavonoid rich orange
juice (272 mg)
Acute




N/A (Healthy adults) High flavanone 100%
orange juice (305 mg)
8 weeks
Park et al., 2020 Randomized single
blind study









Depression Total dietary flavonoid
intake (including
flavanones)
10 year follow up




Dementia Daily citrus intake 5.7 year follow up





Nurk et al., 2010 Cross-sectional study 2031 Elderly adults
(70–74 years)
Cognitive decline Different plant foods
(including citrus intake)
N/A




Stroke incident Different flavonoid
intake (including
flavanones)
6.5 years follow up




Stroke incident Dietary flavonoid intake
(including flavanones)
14 years follow up
testing, citrus fruits had the strongest association with cognitive
test performance. Kendrick object learning, trial making, digit
symbol and block design tasks all showed statistically significant
improvements suggestive of better episodic memory, executive
function, perceptual speed, and visuospatial skills (Table 3).
Following on from these observations, Kean et al. (2015),
examined the chronic consumption of flavanone-rich orange
juice in relation to cognition in 37 healthy volunteers (60–
81 years). The study was a double-blind RCT with a crossover
design and involved consumption of a 500 mL high flavanone
(daily serving of 305 mg – 549 mg hesperidin/L and 60 mg
narirutin/L) orange juice daily for 8 weeks. In support of
the cross-sectional study mentioned above, global cognition
increased in response to chronic consumption of the flavanone-
rich orange juice relative to control. In addition, high flavanone
intake significantly improved recall and nominally increased
executive function, although post hoc analysis found this to
be non-significant (p = 0.06). These effects were independent
of mood and blood pressure which both remained unchanged
(Table 3).
Acute neurological responses to citrus flavonoids
have similarly been investigated (Alharbi et al., 2016;
Lamport et al., 2016). Firstly, in a randomized, double-blind,
placebo-controlled, crossover trial, Alharbi et al. (2016) explored
the cognitive benefits associated with flavonoid-rich orange
juice (272 mg – 220.46 mg hesperidin, 34.54 mg narirutin,
17.14 mg other flavonoids) at 2 and 6 h post-consumption in 24
healthy middle-aged adults (30–65 years). From the cognitive
battery performed, flavonoid rich orange juice consumption
led to higher performance in Simple Finger Tapping (measure
of psychomotor speed) and Continuous Performance Task
(measure of attention and more broadly executive function) at
2 and 6 h respectively. A non-significant trend for higher global
cognitive performance (all tests combined) was also observed,
as well as an increase in subjective alertness. Interestingly,
significant improvements observed in cognition and subjective
alertness at 6 h coincide with an anticipated peak in flavanone
metabolites at 5–7 h (Manach et al., 2003), although this was not
physically measured.
As with the previous study, Lamport et al. (2016) assessed
acute neurological response, this time to a commercially
available high flavanone beverage (HF, 70.5 mg – 42.15 mg
hesperidin, 17.25 mg naringin, 6.75 mg narirutin, 4.3 mg caffeic
acid) and utilizing an additional measure of cerebral blood
flow (CBF). The study was single blind, randomized, cross
over, by design involving healthy adult volunteers (aged 18–
30 years). Participants underwent either cognitive testing 2 h
post consumption (n = 28) or completed an fMRI assessment
of CBF 2 and 5 h post consumption (n = 16). High flavanone
beverage intake significantly increased cerebral perfusion in the
inferior frontal and middle right frontal gyrus in the right
hemisphere at 2 h. Similarly, at 2 h, improvement in digit
symbol substitution test (a measure of executive function) was
seen, correlating with the increased regional perfusion of the
inferior frontal gyrus, known to be involved in executive function
(Aron et al., 2004). Despite the extensive cognitive battery, no
additional effects were found. However, as addressed by the
authors, this study had a number of limitations. In particular,
the fact MRI and cognitive test were performed on separate
individuals, and that cognitive tests were only performed at
2 h limits comparative potential. Additionally, as stated by the
authors, the fact that the participants were generally young and
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highly educated may have limited the response given they were
likely to be optimally functioning (Table 3).
Studies on Depression
Depression is a complex mood disorder which can often be
challenging to treat effectively. Preclinical studies have reported
anti-depressant effects of flavonoids, usually attributable to their
antioxidant and anti-inflammatory characteristics, and inhibition
of monoamine oxidases (Hritcu et al., 2017). An important
serological marker identified in depression is BDNF (involved
in processes within the central nervous system) which has
been observed to be significantly lower in patients with major
depressive disorder compared to non-depressed control groups,
and subsequently recovered antidepressant users (Chen et al.,
2001). Interestingly, BDNF is often increased in response to
flavonoid consumption (Neshatdoust et al., 2016).
In a prospective cohort study following 82,643 women with
no previous diagnosis of depression from the Nurses’ Health
Study (NHS; aged 53–80 years) and Nurses’ Health Study II
(NHSII; aged 36–55 years) throughout a 10-year period, an
inverse association between incident depression and citrus intake,
with greatest flavanone intake (>64.2 mg/day) resulting in
a significant 10% reduction in incident depression risk was
observed. Furthermore, citrus fruit and juice intake of >2
servings/day had HR of 0.82 (Chang et al., 2016).
These anti-depressant effects of citrus flavonoids were recently
put to the test by Park et al. (2020), in a single blind,
randomized control study examining the effects of daily 380 ml
flavonoid rich (FR; 600 ± 5.4 mg flavonoid content) orange
juice consumption on depressive symptoms and gut microbiota
for an 8-week period in young adults (aged 20–30 years).
The results in relation to depression were by no means clear
cut, with no apparent significant differences between high
and low flavonoid groups after 8 weeks. However, compared
with baseline the results suggested potential improvement in
BDNF, and to some extent to the Center for Epidemiological
Studies Depression Scale (CES-D), a psychiatric screening tool
used to detect pre-existing mental disorders, although both
treatments appeared to improve upon baseline CES-D scores
(Table 3).
Studies on Dementia
Despite the preclinical evidence backing the beneficial
effect of citrus flavonoids in models of Alzheimer’s and
Parkinson’s diseases, etc. there remains very limited evaluation at
the human level.
In a retrospective cohort study (Zhang et al., 2017), examined
the association between daily citrus intake and dementia
incidence in 13,373 participants (age ≥ 65 years). FFQs in
combination with the Japanese Long-term Care Insurance
database were used over a 5.7 years follow up period. Overall,
an inverse dose-response relationship was established between
weekly citrus fruit intake and incident dementia, with hazard
ratios for citrus fruit consumption 3–4 times/week and every day
0.92 (95% CI 0.80, 1.07) and 0.77 (95% CI 0.73, 1.01) respectively.
As dementia represents a wide range of neurodegenerative
diseases, lack of further classification limits the extent to which we
can attribute these effects to specific neurodegenerative diseases
and should be considered in future studies (Table 3).
Studies on Schizophrenia
Schizophrenia is a complex psychotic condition affecting
cognition, the cognitive hallmark of schizophrenia being poor
learning and retention of verbal information (Bowie and
Harvey, 2006). In an open label pilot study, 20 outpatients
diagnosed with schizophrenia receiving second generation
antipsychotic medication consumed a flavanone-rich bergamot
polyphenolic fraction (BPF) daily at a dose of 1000 mg/day
for 8 weeks. Daily BPF consumption significantly improved
Wisconsin Card Sorting Test “perseverative errors” and semantic
fluency test. With a trend for other cognitive variables evident
(Bruno et al., 2017) (Table 3).
Studies on Stroke and Stroke Risk
Factors
The protective effects of citrus flavonoids in cerebrovascular
disease are well documented (Testai et al., 2017; Mahmoud
et al., 2019) and appears to extend to stroke incidence.
A prospective cohort study, assessing the association of
dietary flavonoid intake toward stroke risk, followed 69,622
women (30–55 years) from the NHS Study throughout a
14-year period (Cassidy et al., 2012). Although flavonoid
intake was not inversely associated with stroke risk, women
with greatest intake of flavanones > 62.95 mg/day had a
relative risk for experiencing an ischemic stroke of 0.81
compared to lowest intake < 13.72 mg/day. Additionally,
an inverse trend was established between citrus fruit/juice
intake and risk of ischemic stroke. These apparently
protective effects did not influence haemorrhagic strokes
(Scheffers et al., 2018; D’Elia et al., 2020; Zurbau et al.,
2020).
A recent prospective cohort study (Goetz et al., 2016),
utilizing ‘The Reasons for Geographic and Racial Differences in
Stroke’ (REGARDS) database, assessed whether any association
exists between flavonoid intake and incident ischemic stroke
in a biracial cohort. 20,024 participants (>45 years) of whom
flavonoid consumption was determined from FFQ, were
followed for 6.5 years. After multivariable adjustment,
the highest flavanone intake > 48 mg/day was inversely
associated with incidences of ischemic stroke compared to
lowest flavanone intake < 3.9 mg/day. With citrus fruit/juice
consumption displaying similarly reduced risk (HR of 0.69).
In agreement with the above-mentioned study of total
flavonoids and other flavonoid subclasses did not show any
statistically significant association with incident ischemic stroke,
clearly showcasing the importance of the flavanone subclass
(Table 3).
Of particular relevance to the mitigation of stroke risk, and
also neurodegenerative conditions, it is worth briefly mentioning
the influence of citrus flavonoid intake on blood pressure, and
vascular functions. RCTs in which flavonoids were administered
in the form of orange juice have established significant reductions
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in blood pressure (Morand et al., 2011; Valls et al., 2020), pulse
pressure (Valls et al., 2020), while also improving flow-mediated
dilation (Li et al., 2020).
FUTURE PERSPECTIVES AND
CONCLUSION
The preclinical literature search distinguished fundamental
mechanisms central to citrus flavonoids, with protective
effects linked with anti-oxidative and anti-inflammatory action
particularly well established. Yet, there are a number of areas
requiring further investigation. First, the overwhelming majority
of studies to date involve relatively young male animals making it
difficult to establish whether or not the observable effects are sex
or age specific. Nor do we have an understanding of modulation
by either factor. Second, the models employed tend to lean
toward the severe side of the disease spectrum, thus translation
to a healthy aging context, or milder conditions, remains to be
fully determined, although some initial work provides supportive
results (Liaquat et al., 2018). Third, despite recent attention on
the relationship between gut microbiota and polyphenols, and
the apparent ability of citrus flavonoids to mitigate LPS associated
neuroinflammation/NDG, to our knowledge there are no studies
which have explored the role of the microbiota in combination
with citrus flavonoids in the context of brain health and disease.
Finally, as can be seen in Table 1, the impact of citrus flavonoids
upon BBB integrity/function appears to have emerged over the
last couple of years (Cheng et al., 2018; Li et al., 2019; Yang
et al., 2019; Lee et al., 2020), particularly for kaempferol, and
therefore should be examined in further studies, especially as
BBB integrity has similarly been associated with gut microbiota
(Braniste et al., 2014).
From a human perspective, there is an obvious lack of
human clinical studies which needs to be addressed if a
robust assessment of therapeutic potential is to be made.
Similarly, very few human studies have followed up on the
mechanistic insights established in the preclinical setting.
Future human studies should take note of the limitations
arising from other human studies in which nutraceuticals
were assessed in the context of brain health and disease, for
example ensuring optimal participant targeting (in demographics
where significant change is most likely to occur), dosage,
timing, and duration of treatment for measurable effects
to be established.
The complex mixtures of polyphenols present in citrus fruits
and juices and their bioactive nuances likely convey greater
benefit than one purified compound, accumulatively acting upon
multiple targets, and producing synergistic effects. Given the
multifactorial nature of neurodegenerative diseases, one would
speculate that this complex form would therefore offer greater
efficacy, but this is yet to be fully determined.
In conclusion, although significant work remains to fully
establish the benefits of citrus polyphenols in brain health and
disease, the accumulating in vitro and preclinical data combined
with the support of steadily emerging human studies indicates
future potential.
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